US · Healthcare

General Cannabis Corp (CANN)

Drug Manufacturers - Specialty & Generic

General Cannabis Corp (CANN) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for CANN

P/E ratio
18.00

General Cannabis Corp (CANN) — FAQ

What is CANN's P/E ratio?

The price-to-earnings (P/E) ratio for General Cannabis Corp (CANN) is 18.00 (data as of 2026-03-23).

Does General Cannabis Corp pay a dividend?

Dividend yield is not available in the current snapshot for General Cannabis Corp (CANN). Check the MyAverix Finance app for the latest dividend data.

What sector is General Cannabis Corp in?

General Cannabis Corp (CANN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CANN listed on?

CANN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play